Cancer Protocols & Metabolic Library (Directory)

⚠️ Medical Disclaimer: This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. All protocols and drug information discussed here should be reviewed with a qualified physician before implementation. Repurposed drugs are not approved by regulatory agencies (FDA, EMA, etc.) for the treatment of cancer unless otherwise stated.

The Complete Integrative Oncology Resource Hub — 2026 Edition An evidence-informed guide combining the Cancer Advisor Protocols with Dr Paul Marik’s Cancer & Metabolic Library — covering repurposed drugs, metabolic cancer theory, diet, nutraceuticals, prevention, and cancer-specific treatment playbooks. Built for patients, caregivers, clinicians, and researchers navigating beyond standard-of-care.

 Quick Navigation  Understanding Cancer Through a Different Lens 溺 The Metabolic Foundations of Cancer ♟ Building the Metabolic Strategy ⚡ The Warburg Revolution 復 Diet & Metabolism 溺 Understanding Cancer Mutations  Repurposed Drugs  Nutraceuticals  Cancer-Specific Playbooks  Prevention: ROOTS & I-PREVENT Protocols  Treatment Protocols Index  Case Series by Cancer Type  Conventional Oncology & Metabolic Lens ❓ FAQ

 Understanding Cancer Through a Different Lens

The dominant paradigm of oncology treats cancer as a genetic disease — a collection of somatic mutations driving uncontrolled cell division. An alternative framework, increasingly supported by researchers including Thomas Seyfried, Paul Marik, and the FLCCC Alliance, frames cancer primarily as a metabolic disease driven by mitochondrial dysfunction and aberrant energy metabolism (the Warburg Effect). Both frameworks are complementary, not mutually exclusive. Understanding both opens the door to a wider range of therapeutic strategies. Key concept: Cancer cells preferentially ferment glucose to lactate even in the presence of oxygen (aerobic glycolysis / Warburg Effect). This metabolic vulnerability is a therapeutic target.

• Marik’s Cancer & Metabolic Healing Playbook (Dr Paul Marik) • What is Integrative Oncology? • Cancer Is a Metabolic Disease ⭐ • Oncologists: Cancer is a Metabolic Disease — Time to Wake Up

• Expert Explains: Cancer May Be a Metabolic Disease • The Societal Impact of Cancer • What COVID Taught Me About Medicine (Dr Paul Marik) • Thomas Seyfried Protocol: Ketogenic Diet That Starves Cancer

溺 The Metabolic Foundations of Cancer

Cancer’s metabolic dependencies create targetable vulnerabilities beyond what conventional genetics-based precision oncology addresses. Understanding these foundations is prerequisite to designing a rational integrative strategy.

Topic	Description	Source
Cancer Stem Cells	The role of cancer stem cells in treatment resistance, recurrence, and metastasis	Dr Paul Marik
Cancer Immunity & TME	How the tumor microenvironment suppresses immune response and how to reverse it	Dr Paul Marik
Reprogramming the TME	Repurposed drugs and nutraceuticals that remodel immune suppression in tumors	Dr Paul Marik
Repurposed Drugs: New Frontier ⭐	Foundational overview of repurposed drugs and nutraceuticals as cancer adjuncts	Dr Paul Marik
Glycolytic Enzyme Targeting	Targeting HK2, GLUT1, LDHA and other glycolytic enzymes with drugs & nutraceuticals	Dr Paul Marik
FAO & OXPHOS-Dependent Cancers	Some cancers depend on fatty acid oxidation rather than glycolysis — how to address them	Dr Paul Marik
Warburg + FAO: A Clearer Understanding	Reconciling the Warburg Effect with fatty acid oxidation dependency in cancer	Dr Paul Marik
Mitochondrial-Stem Cell Connection	Targeting the mitochondrial-stem cell axis to eliminate therapy-resistant cancer cells	Cancer Advisor

♟ Building the Metabolic Strategy: The Five-Axis Model

Dr Paul Marik’s Five-Axis Metabolic Trap is the strategic framework underlying the metabolic approach to cancer. It argues that attacking cancer on five simultaneous axes — glycolysis, glutamine, fatty acid oxidation, immune/TME reprogramming, and cancer stem cells — closes the escape routes that drive treatment resistance. Ivermectin is specifically identified as a “network amplifier” within this model, with demonstrated activity across multiple axes simultaneously.

AXIS 1 Glycolysis / Glucose

AXIS 2 Glutamine / OXPHOS

AXIS 3 Fatty Acid Oxidation

AXIS 4 Immune / TME Reprogramming

AXIS 5 Cancer Stem Cell Suppression

Article	Priority
The Metabolic Trap: The Five-Axis Metabolic Pressure Model	⭐ Essential
Ivermectin: A Network Amplifier in the Metabolic Cancer Trap	⭐ Essential
Cancer Resistance and Interventions to Mitigate Resistance — Part 1	Core Reading
Staying One Step Ahead of Cancer Resistance — Part 2	Core Reading
To Cycle or Not to Cycle: Rethinking Doxycycline and Mebendazole	⭐ Essential
Perioperative Drugs to Reduce Metastases	⭐ Essential
Press Pulse Protocol 2.0 (2026): Complete Immunometabolic Framework	Cancer Advisor
The 3/4 Day Metabolic Pulse Framework: Pharmacological Rationale	Cancer Advisor
Integrating Fenbendazole, Ivermectin & Mebendazole: The 2026 Protocol	Cancer Advisor
The Integrated Metabolic Cancer Framework 2026	Cancer Advisor

⚡ The Warburg Revolution: A Series

Series under development by Dr Paul Marik. Published titles will be linked as released. • The Deadliest Cancers Have the Strongest Warburg Effect • Lactate — The Fuel That Builds Tumors • c-Myc, GLUT1, and Hexokinase-2 — Cancer’s Sugar Addiction Machinery • PI3K/AKT/mTOR: The Master Switch of Cancer Metabolism (Cancer Advisor) • Nutraceuticals That Target the Warburg Network • Repurposed Drugs That Target Cancer Metabolism • How Glucose and Insulin Fuel Tumor Growth — and What to Do About It (Cancer Advisor) • Beyond Warburg: Jane McLelland’s Powerful Critique of Metabolic Cancer Theory

復 Diet & Metabolism in Cancer

Diet is the foundation of the metabolic approach to cancer. Restricting glucose availability through ketogenic, low-carbohydrate, or time-restricted eating approaches can starve cancer cells while supporting healthy tissue.

Article	Source
Why Diet is the Foundation of the Metabolic Approach to Cancer ⭐	Dr Paul Marik
Dietary Interventions in Cancer (Part 1)	Dr Paul Marik
What to Eat When You Have Cancer (Part 2)	Dr Paul Marik
Role of Fasting and Fasting-Mimicking Diets (FMDs) During Chemotherapy	Dr Paul Marik
Insulin Resistance: The Silent Engine of Cancer Growth	Dr Paul Marik
Eat These Foods to Starve Cancer Cells to Death (2026 Update)	Cancer Advisor
Pancreatic Cancer and Insulin Resistance: The Overlooked Connection	Cancer Advisor
Can Diet & Lifestyle Influence Your Cancer Risk? Let the Science Speak	OneDayMD
I-TREAT Cancer Protocol: Diet and Lifestyle Guide For Cancer	OneDayMD

溺 Understanding Cancer Mutations & Precision Oncology

Series primarily under development by Dr Paul Marik. Cancer Advisor articles linked where published. • The Mutation Trap: The Billion Dollar Illusion of Precision Oncology • What Is a KRAS Mutation — and Why Does It Matter? • KRAS Inhibitors (2026): The Complete Guide to Targeted Therapy (Cancer Advisor) • Understanding the BRAF Mutation: One of Oncology’s Biggest Success Stories • TP53: The Guardian of the Genome • PIK3CA and the PI3K–AKT–mTOR Pathway • BRCA1 and BRCA2: Beyond Breast Cancer • EGFR: The First Great Targeted Therapy • MYC: The Master Driver of Cancer Growth • APC and the Origins of Colorectal Cancer • Cancer Biomarker Testing Guide: CEA, CA-125, PSA and Beyond (Cancer Advisor) • PD-L1 vs TMB vs MSI-H: Which Biomarker Best Predicts Immunotherapy Response? (Cancer Advisor) • Tumor Mutation Burden (TMB): The Immunotherapy Biomarker Explained (Cancer Advisor)

 Repurposed Drugs in Cancer

Evidence Note: Repurposed drugs in oncology represent an exciting but mostly pre-clinical research area. Most evidence is CEBM Level 3–5 (observational, case reports, preclinical). None of the drugs below are approved as standalone cancer treatments unless specifically noted. Always use under physician supervision.

Drug	Original Indication	Proposed Anticancer Mechanisms	Key Resources
Fenbendazole	Veterinary anthelmintic	Microtubule disruption, glycolysis inhibition (HK2), p53 activation, autophagy induction	Joe Tippens Protocol 2026 | What the Science Shows
Ivermectin	Human/veterinary antiparasitic	P-glycoprotein inhibition, WNT/β-catenin inhibition, SHP2 inhibition, TME reprogramming, cancer stem cell suppression	Marik: Ivermectin & Cancer | 2026 Protocol Review
Mebendazole	Human anthelmintic	Multi-axis metabolic inhibition, tubulin disruption, anti-angiogenic, BCL-2 inhibition	Marik: Mebendazole | Dosing Question ⭐
Metformin	Type 2 diabetes	AMPK activation, mTOR inhibition, Complex I inhibition, anti-proliferative, insulin sensitization	Marik: Metformin — Most Important Repurposed Drug?
Doxycycline	Antibiotic	Mitochondrial protein synthesis inhibition, cancer stem cell targeting, anti-angiogenic	Marik: Doxycycline
Melatonin	Sleep / circadian rhythm	Antioxidant, immune modulation, anti-proliferative, apoptosis induction, anti-angiogenic	Marik: Cancer Hates Darkness
Statins	Cholesterol / cardiovascular	Mevalonate pathway disruption, anti-proliferative, pro-apoptotic, anti-inflammatory	Marik Cancer Library (in development)
Aspirin / Diclofenac	NSAID / anti-inflammatory	COX-2 inhibition, NF-κB suppression, prostaglandin E2 reduction, anti-metastatic	Marik Cancer Library | Cancer Advisor: Top 17 Alt Treatments
Low Dose Naltrexone	Opioid antagonist (low dose)	Immune modulation, TLR4 antagonism, endorphin upregulation, OGF pathway activation	Marik Cancer Library (in development)
Itraconazole	Antifungal	Hedgehog pathway inhibition, anti-angiogenic, VEGFR2 blockade, P-glycoprotein inhibition	Marik Cancer Library (in development)
Methylene Blue	Methemoglobinemia / psychiatric	Mitochondrial electron transport chain support, oxidative stress in cancer cells, photodynamic effects	Methylene Blue for Cancer | Marik: Caution with MB & Red Light
DMSO	Industrial solvent / anti-inflammatory	Cell differentiation induction, carrier for combination therapies, anti-proliferative	DMSO for Cancer (3-Part Series)

‍⚕️ Dr William Makis Protocols (2026) Dr William Makis MD (McGill Medicine; 110+ peer-reviewed publications) has been treating cancer patients using repurposed antiparasitic agents since 2023, publicly documenting protocols and outcomes. • Dr William Makis Ivermectin Protocol 2026: Complete Guide • Dr William Makis’s Recommended Ivermectin Dosages for Cancer (2026) • Ivermectin and Fenbendazole: Treating Turbo Cancer — Dr William Makis

 Nutraceuticals & Anti-Cancer Supplements

Nutraceutical	Key Anticancer Mechanisms	Evidence Level	Resource
Vitamin D3	Anti-proliferative, pro-apoptotic, immune modulation, VDR signalling	Tier 2 — Observational + RCTs	Marik: Vitamin D
Curcumin (Turmeric)	NF-κB inhibition, anti-inflammatory, pro-apoptotic, anti-angiogenic	Tier 2 — Preclinical + Observational	Cancer Advisor Supplement Guide
EGCG (Green Tea)	VEGF inhibition, PI3K/AKT inhibition, cancer stem cell suppression	Tier 2 — Preclinical + Observational	Marik: EGCG
Berberine	AMPK activation, mTOR inhibition — “natural metformin”	Tier 2 — Preclinical + some RCTs	Marik: Berberine
Sulforaphane	Nrf2 activation, Phase II detoxification, histone deacetylase inhibition	Tier 2 — Preclinical	Marik: Sulforaphane
Omega-3 Fatty Acids	Anti-inflammatory (PGE2 suppression), anti-metastatic, immune modulation	Tier 2 — Observational + RCTs	Top 10 Supplements 2026
Modified Citrus Pectin	Galectin-3 inhibition, anti-metastatic, immune-enhancing	Tier 2 — Preclinical + pilot studies	Marik: MCP
Molecular Hydrogen	Selective antioxidant, anti-inflammatory, mitochondrial protection	Tier 3 — Emerging RCTs	Cancer Advisor Supplement Guide

 Read Full Anti-Cancer Supplement Review (2026 Update)

 Cancer-Specific Playbooks

Cancer-specific playbooks apply the metabolic and integrative framework to individual cancer types. Dr Paul Marik’s “playbook” series provides condition-specific strategic guidance. The Cancer Advisor case series provide patient-level outcome data across 28 cancer types.

 Dr Paul Marik Playbooks • Prostate Cancer (Part 1) • Prostate Cancer (Part 2 — Neuroendocrine) • Breast Cancer (in development) • Colorectal Cancer (in development) • Pancreatic Cancer (in development) • Follicular Lymphoma (in development) • Neuroendocrine Tumors Part 1 & 2 (in development) • Thyroid Cancer (in development) • Uterine Cancer (in development) • HPV-Associated Oral Cancer (in development) • Childhood Cancers (in development)

 Cancer Advisor Deep Dives • Prostate Cancer • Pancreatic Cancer • Metastatic Colorectal Cancer • Cold vs Hot Tumors & Immunotherapy • MSI-H & Immunotherapy • Glioblastoma & Repurposed Drugs • Oncolytic Virotherapy in Colorectal • CAR-T vs CAR-NK Cell Therapy

 Prevention: ROOTS & I-PREVENT Protocols

 ROOTS Protocol (Dr Paul Marik) A systemic cancer prevention framework addressing root metabolic and lifestyle drivers of cancer initiation and promotion. • What the Public Is Not Told About Cancer Prevention • The ROOTS Protocols ⭐ • Preventing Breast Cancer • Preventing Colorectal Cancer • Preventing Melanoma (Parts 1 & 2) • Preventing Prostate Cancer • PSA Screening: What You Need to Know (Marik Substack — titles publishing progressively)

 I-PREVENT Protocol (OneDayMD) OneDayMD’s evidence-based cancer prevention framework covering diet, lifestyle, supplements, and actionable habits. • I-PREVENT CANCER Protocol 2026 • Evidence-Based Guide to Cancer Prevention • Best Anti-Cancer Supplements (Vit D3, K2, Omega-3, Turmeric, Vit C, Mg, H2, Zinc, Garlic) • Lifestyle — smoking cessation, weight, exercise, stress • Diet — plant-based, Mediterranean, avoid processed foods • The Cancer Prevention Habit Hack Nobody Talks About (VILPA)

 Treatment Protocols Index

Protocol	Core Components	Source
Fenbendazole Joe Tippens Protocol	Fenbendazole 222mg + Vitamin E succinate + Curcumin + CBD (3 on / 4 off)	Joe Tippens / Cancer Advisor 2026
Cancer Stem Cell Protocol	Ivermectin + Fenbendazole + Mebendazole combination targeting CSCs	OneDayMD 2024
Integrated Metabolic Cancer Protocol 2026	Full five-axis protocol: IVM + MBZ + FBZ + Metformin + nutraceuticals + diet + cycling	Cancer Advisor 2026
Press Pulse Protocol 2.0 (2026)	Seyfried-inspired: ketogenic diet (press) + metabolic pulse (chemotherapy/repurposed drugs)	Cancer Advisor 2026
3/4 Day Metabolic Pulse Framework	Evidence-based cycling regimen for repurposed drugs to prevent resistance	Cancer Advisor 2026
MTD vs Metronomic Chemotherapy: The Decision Nobody Explains	Comparing high-dose vs low-dose metronomic chemo scheduling and integrative layering	Cancer Advisor 2026
Thomas Seyfried Protocol	Water fasting + ketogenic diet + hyperbaric oxygen + press-pulse metabolic therapy	OneDayMD / Seyfried
IMA: Repurposed Drugs & Metabolic Interventions in Cancer	Independent Medical Alliance evidence synthesis and clinical guidance	FLCCC / IMA

 Case Series by Cancer Type (700+ Patient Records)

Evidence Level: All case reports represent CEBM Level 4–5 evidence (case reports, expert opinion). This compilation is hypothesis-generating only. Testimonials are uncontrolled anecdotal accounts shared voluntarily by patients. No clinical trials of these protocols currently exist.

Breast Cancer (45 cases) Brain Cancer / Glioblastoma (7 cases) Colorectal Cancer (23 cases) Endometrial Cancer (6 cases) Esophageal & Stomach Cancer (6 cases) Head & Neck Cancer (10 cases) Kidney Cancer (10 cases)

Liver Cancer (HCC) (3 cases) Lung Cancer (18 cases) Leukemia (AML & CLL) (2 cases) Lymphoma (8 cases) Melanoma / Skin Cancer (8 cases) Multiple Myeloma (2 cases) Ovarian Cancer (4 cases)

Pancreatic Cancer (23 cases) Prostate Cancer (33 cases) Sarcoma (3 cases) Thymus Cancer Turbo Cancer Uterine Cancer (6 cases) Stage IV Urothelial Cancer → Remission

 Browse the Full 700+ Patient Case Series Compilation

 Conventional Oncology Through a Metabolic Lens

• Overview of Chemotherapy and Metronomic Dosing (Dr Marik) • Integration of Metronomic Chemotherapy with Repurposed Drugs ⭐ (Dr Marik) • Bridging the Gap: Repurposed Drugs Between Conventional Therapy Cycles (Dr Marik) • The Chemotherapy Decision Nobody Explains: MTD vs Metronomic Protocols (Cancer Advisor) • New Cancer Treatment Breakthroughs 2026: Immunotherapy & Beyond (Cancer Advisor) • The Abscopal Effect: How Radiation Therapy Can Trigger Systemic Immune Response (Cancer Advisor) • CyberKnife Radiotherapy: Precision Cancer Treatment Explained (Cancer Advisor) • Monitoring the Progression of Cancer (Marik — in development) • Maintenance Therapy After Achieving NED (Marik — in development) • When Treatment Fails: What Next? (Marik — in development)

烙 Using AI to Personalize Your Research

AI tools like Claude (Anthropic), ChatGPT (OpenAI), Gemini (Google), and Perplexity AI can help you synthesize the information across this library and personalize it to your specific cancer type, mutation profile, treatment history, and goals. Here’s how: 烙 Claude (claude.ai) Upload your pathology report, scan results, or blood work. Ask: “Based on my KRAS G12D mutation and Stage 3 pancreatic cancer, which repurposed drugs from the Marik protocol are most relevant to my situation?”  ChatGPT Use the “Browse” function to fetch and summarize specific articles from this library. Ask: “Summarize the five-axis metabolic trap for a patient with triple-negative breast cancer.”  Perplexity AI Ideal for sourced answers. Ask: “What is the current evidence for ivermectin in colorectal cancer? Reference Dr Paul Marik and Cancer Advisor sources.” ✨ Gemini Upload your medical documents directly. Ask: “Based on my oncologist’s report, what questions should I ask about integrative metabolic therapy?” Important: AI tools synthesize and summarize; they do not replace physician consultation. Use AI outputs as conversation starters with your oncologist or integrative medicine physician.

 What Sets The Cancer Advisor Apart

✅ Evidence-Tiered Framework All content is graded by CEBM evidence level (Tier 1–4), distinguishing RCT-grade evidence from case reports and expert opinion. ✅ Independent & Unsponsored No pharmaceutical sponsorship. Content covers both conventional and integrative approaches without institutional bias. ✅ Southeast Asian & Global Relevance Regional context for Malaysia, Singapore, and broader Asia-Pacific, where access to novel therapies and pricing dynamics differ significantly from Western markets.

✅ Patient-First Framing Complex science translated into actionable, decision-ready information for patients, caregivers, and health-conscious individuals — not just clinicians. ✅ Living Document Updated continuously as research evolves. Over 160 articles published in 2026 alone across the Cancer Advisor network. ✅ Integrates Dr Paul Marik’s Library The only platform synthesizing Dr Marik’s Cancer & Metabolic Library with Cancer Advisor’s 700+ case series database in one navigable hub.

 Resource Guides & Directories

Resource	What You’ll Find
Find Oncologists & Integrative Cancer Clinics	Directory of integrative oncologists and cancer treatment centres globally
Cancer Types by System	Complete guide to cancer by organ system and biology
Integrative Oncology Treatment Directory	Comprehensive listing of integrative cancer treatment modalities and resources
Cancer Research: Natural Alternatives	Curated research database on natural and complementary cancer approaches
The Immunotherapy Revolution Series	Multi-part deep dive into checkpoint inhibitors, CAR-T, and cancer immunotherapy
The Wellness Company (TWC) — Find a Doctor	Access to integrative medicine physicians. Use code ONEDAYMD for referral discount.

❓ Frequently Asked Questions

What is the Cancer Advisor Protocols & Metabolic Library? It is a comprehensive, evidence-informed resource hub covering every major aspect of cancer — from metabolic theory and repurposed drugs to diet, nutraceuticals, prevention protocols, and cancer-specific treatment playbooks. It integrates content from the Cancer Advisor editorial team and Dr Paul Marik’s Cancer & Metabolic Library, designed for patients, caregivers, and healthcare professionals. What is the metabolic theory of cancer? The metabolic theory of cancer proposes that cancer is fundamentally a metabolic disease driven by dysfunctional mitochondria and dependence on glucose fermentation (glycolysis), rather than purely a genetic disease. This framework opens the door to metabolic therapies including ketogenic diets, fasting, and repurposed drugs targeting cancer metabolism. It is complementary to, not a replacement for, conventional genetic oncology approaches. What is the five-axis metabolic trap model? Dr Paul Marik’s five-axis metabolic trap model addresses cancer through five simultaneous pressure points: (1) glucose/glycolysis inhibition, (2) glutamine pathway targeting, (3) fatty acid oxidation disruption, (4) immune system reprogramming and tumor microenvironment modulation, and (5) cancer stem cell suppression. Ivermectin is described as a “network amplifier” within this framework, acting across multiple axes simultaneously. What is the Joe Tippens fenbendazole protocol? The Joe Tippens Protocol involves off-label use of fenbendazole (222mg/day, 3 days on / 4 days off) combined with Vitamin E succinate, curcumin, and CBD oil. Joe Tippens popularized this after claiming remission from metastatic small-cell lung cancer in 2017. As of 2026, he remains cancer-free over 8 years. Fenbendazole has no regulatory approval for human cancer treatment and evidence remains preclinical and anecdotal. Always consult a physician before starting any protocol. What nutraceuticals have the strongest anticancer evidence? Vitamin D3, Curcumin, EGCG (Green Tea Extract), Omega-3 Fatty Acids, Melatonin, Berberine, Sulforaphane, Modified Citrus Pectin, Magnesium, and Molecular Hydrogen have the broadest evidence base. Each has a different evidence tier and mechanism of action. See the full supplement review for dose, evidence level, and cancer-type relevance. What is the ROOTS prevention protocol? The ROOTS protocol is Dr Paul Marik’s evidence-informed framework for cancer prevention, addressing lifestyle, diet, metabolic health, and targeted supplementation to reduce cancer risk at a systemic level. It includes cancer-specific prevention guidance for breast, colorectal, melanoma, and prostate cancers. Is this site a substitute for professional medical advice? No. The Cancer Advisor is for educational purposes only. It does not replace diagnosis, treatment planning, or monitoring by qualified healthcare professionals. Always discuss any new treatment options or protocols with your oncologist or integrative medicine physician before making any decisions. If you have stage 4 cancer, do not delay or abandon conventional treatment without physician guidance.

Ready to Go Deeper? Explore the full Cancer Advisor site, browse case series by cancer type, or contact us for collaboration and enquiries.  Cancer Advisor Home  Browse Cancer Types ✉️ Contact Us

Cancer Advisor | OneDayMD Editorial Team • Last Updated: June 2026 • About Us • Privacy Policy This page is a living document and is updated continuously as new research and articles are published across the Cancer Advisor network. Content is for educational purposes only. © 2020–2026 OneDayMD.com. All Rights Reserved.